跳至主要内容
临床试验/EUCTR2008-002373-12-GB
EUCTR2008-002373-12-GB进行中(未招募)不适用

Effect of Spironolactone on Exercise Capacity in functionally impaired older people without heart failure: a double blind placebo controlled trial - Spironolactone and exercise capacity in older people

niversity of Dundee0 个研究点目标入组 120 人开始时间: 2008年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • People over the age of 65 years, with self reported difficulties in activities of daily living
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A clinical diagnosis of symptomatic heart failure according to ESRC criteria
  • Asymptomatic left ventricular systolic dysfunction
  • Already taking spironolactone
  • On ACE inhibitor or angiotensin receptor blocker
  • Systolic BP <100mmHg
  • Serum potassium >5.0 mmol/l
  • Serum sodium <130mmol/l
  • Creatinine >200 umol/l
  • eGFR <30ml
  • Addison’s disease
  • Previous reported intolerance of spironolactone
  • Cognitive impairment precluding informed consent
  • Wheelchair bound

研究者

发起方
niversity of Dundee

相似试验

Effect of Spironolactone on Exercise Capacity in... | 临床试验